HB 1466 (2022)
Protect prescriptions for off-label use
This bill became law.
Last updated 2024-02-27 4:24 pm
Summary:
Allows a physician, physician assistant, and advanced practice registered nurse (APRN) to prescribe an FDA approved drug for an off-label indication (e.g. prescribing ivermectin for COVID-19). The bill also prohibits disciplinary action against a pharmacist for filling a valid prescription for off-label use.
A conference committee of representatives and senators amended the bill to require informed consent from the patient in some circumstances before providing an off-label prescription.
Status:
Status Detail:
Signed by Governor
Public Hearing Date:
04/06/2022 10:00 am
Public Hearing Location:
SH Room 100
House Voting Date:
03/10/2022
Senate Voting Date:
05/26/2022
The data you see here is pulled daily from official government databases. The bill summary is created by Citizens Count staff. Learn more about our methodology for summarizing and updating bills.
Browse related articles and bills:
